New Small-Molecule Synthetic Antimycobacterials
2005; American Society for Microbiology; Volume: 49; Issue: 6 Linguagem: Inglês
10.1128/aac.49.6.2153-2163.2005
ISSN1098-6596
AutoresLluís Ballell, Robert A. Field, Ken Duncan, Robert J. Young,
Tópico(s)Cancer therapeutics and mechanisms
ResumoDrugs for treating tuberculosis (TB) have been available for over half a century, and yet the incidence of disease worldwide continues to rise year by year. In 2002, the last year for which statistics are available, it is estimated that 24,000 people developed active disease and close to 5,000
Referência(s)